Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Operating Leases (2020 - 2025)

Historic Operating Leases for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to -$116314.0.

  • Neuphoria Therapeutics' Operating Leases fell 33347.79% to -$116314.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$116314.0, marking a year-over-year decrease of 33347.79%. This contributed to the annual value of $243603.0 for FY2023, which is 3626.1% down from last year.
  • Neuphoria Therapeutics' Operating Leases amounted to -$116314.0 in Q4 2025, which was down 33347.79% from $19322.0 recorded in Q1 2025.
  • Over the past 5 years, Neuphoria Therapeutics' Operating Leases peaked at $447698.0 during Q4 2021, and registered a low of -$116314.0 during Q4 2025.
  • For the 5-year period, Neuphoria Therapeutics' Operating Leases averaged around $159136.5, with its median value being $89469.0 (2024).
  • As far as peak fluctuations go, Neuphoria Therapeutics' Operating Leases crashed by 3673.96% in 2023, and later plummeted by 33347.79% in 2025.
  • Quarter analysis of 5 years shows Neuphoria Therapeutics' Operating Leases stood at $447698.0 in 2021, then fell by 14.63% to $382188.6 in 2022, then tumbled by 36.74% to $241774.1 in 2023, then crashed by 79.39% to $49818.0 in 2024, then plummeted by 333.48% to -$116314.0 in 2025.
  • Its last three reported values are -$116314.0 in Q4 2025, $19322.0 for Q1 2025, and $49818.0 during Q4 2024.